14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ACAD stock ended at $17.25. This is 1.47% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 3.31% from a day low at $16.76 to a day high of $17.31.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Dec 15, 2021 $23.13 $24.42 $22.19 $24.38 1 848 975
Dec 14, 2021 $22.55 $23.47 $22.42 $23.00 1 302 518
Dec 13, 2021 $22.30 $23.25 $22.21 $22.90 1 508 916
Dec 10, 2021 $22.61 $23.15 $22.13 $22.26 1 294 804
Dec 09, 2021 $21.74 $23.35 $21.57 $22.62 1 988 885
Dec 08, 2021 $21.59 $21.96 $21.12 $21.78 1 597 675
Dec 07, 2021 $21.80 $21.86 $19.81 $21.32 5 757 934
Dec 06, 2021 $18.82 $19.49 $18.50 $19.40 2 514 559
Dec 03, 2021 $20.00 $20.00 $18.50 $18.79 1 155 303
Dec 02, 2021 $18.90 $19.99 $18.75 $19.94 1 078 703
Dec 01, 2021 $19.01 $19.98 $18.87 $18.90 1 022 025
Nov 30, 2021 $18.65 $19.24 $18.57 $19.20 1 135 812
Nov 29, 2021 $19.07 $19.49 $18.82 $18.84 1 092 385
Nov 26, 2021 $19.45 $19.90 $18.58 $18.79 890 361
Nov 24, 2021 $19.32 $19.97 $19.04 $19.78 676 953
Nov 23, 2021 $19.21 $19.55 $18.79 $19.49 950 795
Nov 22, 2021 $19.01 $19.63 $18.96 $19.29 885 546
Nov 19, 2021 $18.93 $19.53 $18.85 $19.15 730 630
Nov 18, 2021 $19.59 $19.67 $18.82 $18.95 1 515 527
Nov 17, 2021 $20.27 $20.75 $19.39 $19.48 1 258 040
Nov 16, 2021 $19.83 $20.48 $19.43 $20.46 2 377 695
Nov 15, 2021 $20.91 $20.93 $19.75 $19.77 1 278 804
Nov 12, 2021 $20.73 $20.85 $20.42 $20.65 1 044 274
Nov 11, 2021 $20.31 $21.20 $20.31 $20.68 761 472
Nov 10, 2021 $21.56 $21.66 $20.28 $20.34 1 476 938
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT